HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata: a prospective study.

Abstract
Thirty-seven patients with previously untreated perianal condylomata acuminata were randomly treated by application of 25 per cent podophyllin or scissor excision. The result of treatment was assessed by an independent observer. At 6 weeks, scissor excision completely cleared the warts from 16 of 18 patients (89 per cent) compared with 15 of 19 patients (79 per cent) treated with podophyllin. Following complete clearance by surgery, two patients had recurrent warts at 18 weeks and a further single patient at 42 weeks, giving a cumulative recurrence rate of 19 per cent. In contrast, five of 15 patients whose warts were cleared by podophyllin had recurrent warts at 18 weeks and a further four at 42 weeks representing a cumulative recurrence rate of 60 per cent (X2 = 3.95, d.f. = 1, P = 0.05). At 42 weeks six patients (32 per cent) were free of disease in the podophyllin group compared with 13 (72 per cent) in the scissor excision group (X2 = 4.6, d.f. = 1, P = 0.03). Scissor excision is therefore preferable to podophyllin application in the treatment of perianal condylomata acuminata.
AuthorsH T Khawaja
JournalThe British journal of surgery (Br J Surg) Vol. 76 Issue 10 Pg. 1067-8 (Oct 1989) ISSN: 0007-1323 [Print] England
PMID2597953 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Podophyllin
Topics
  • Adult
  • Anal Canal (surgery)
  • Anus Neoplasms (drug therapy, surgery)
  • Condylomata Acuminata (drug therapy, surgery)
  • Female
  • Genital Neoplasms, Female (drug therapy, surgery)
  • Genital Neoplasms, Male (drug therapy, surgery)
  • Genitalia (surgery)
  • Humans
  • Male
  • Middle Aged
  • Podophyllin (therapeutic use)
  • Prospective Studies
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: